Bringing the fundamentals into focus…
Back to BioNTech SE
How BioNTech SE stacks up
BNTX · against 454 other Healthcare companies listed in US-listed
Growth
18/ 100
Near the bottom of its peers.
Ranked #388 of 455 · scores higher than 14% of peers
Bars: peers in each 10-point band of the growth score26 peers with a growth score of 10–19, including BNTX · Click a bar to see the companies
Why growth scores 18?
Weighted metrics compared with all Healthcare companies.Mainly because of its 3-year revenue growth, which is weaker than most Healthcare peers.
- slower revenue growth over three years: weaker than 98% of peers. 3-year revenue growth: -45.1% vs peer median 5.8%
- Revenue growth is close to the peer norm. Revenue growth: 4.3% vs peer median 6.1%
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = BNTX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BNTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 4.3% | 11.0% | 32% | 33% | |
| Earnings per share growthHigher is better · 171 reported | Not reported | 21.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 433 reported | -45.1% | 11.0% | 3% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around BNTX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 382 | 66.3B USD | 20 | 30 | |
| 382 | 705M USD | 20 | 32 | |
| 386 | 1.2B USD | 19 | 39 | |
| 386 | 966M USD | 19 | 33 | |
| 388 | 21.8B USD | 18 | 32 | |
| 388 | 471M USD | 18 | 21 | |
| 388 | 474M USD | 18 | 46 | |
| 388 | 1.5B USD | 18 | 30 | |
| 388 | 528M USD | 18 | 58 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score